News About: Pharm. Industry
KFDA to start on-spot GMP inspection on herbal medicines
The Korea Food and Drug Administration says it will begin to make its on-site inspection on four manufacturing sites of SK Chemicals’ Joins, an oriental medicine, from this week.
Joins have been manufactured in thr...
More tax exemptions set for R&D spending
Korea seeks to expand tax exemptions for corporate investment in research and development (R&D) as part of efforts to stimulate state-run and private companies’ R&D spending in the era of free trade agreements (FTAs)....
Autologous Cultured Adipose-Derived Stem Cells to be commercialized in second half
The effective management of fistulas in patients with Crohn's disease presents an extremely challenging problem. Mesenchymal adult stem cells extracted from certain tissues, such as adipose tissue, can differentiate i...
Daewoong to open R&D center in US
Daewoong Pharm said it has established its US based research and development center in Maryland.
It is a part of the company's effort to accelerate the development new drugs. The measure comes after Daewoong has co...
Korean named AstraZeneca medical advisor in Asia
Sohn Ji-woon, executive managing director of Astra Zeneca Korea, has been newly appointed AstraZeneca headquarters’ medical advisor to head the oncology sector of the multinational firm in Asia.
A graduate of Seoul...
Korean biotech firm signs $290 million deal with Roche
Digital Biotech Co., a local biotech company, said on January 19 that it has signed a $290 million deal with Roche Holding AG to transfer its candidate dementia treatment to the Switzerland based pharmaceutical giant....
Pharmaceutical firms still offering rebates
Though the industry is striving to get rid of the rampant rebate practice, insiders remain skeptical.
“If the hospitals do not step up to root out the irregularities, rebates will always remain. Hospitals do not su...
Handok donate to Haiti relief drugs
Handok Pharm, Korea’s leading pharmaceutical corporation, says the company is joining the global relief efforts for earthquake-devastated Haiti.
Handok has recently decided to make a donation of pharmaceuticals wor...
93 drugmakers face damage suits
The state-run National Health Insurance Corporation says it has filed six suits against a total of 93 pharmaceutical firms, for financial damage caused by data fabrication on bioequivalence testing.
“We have filed ...
Drug makers at odds over campaign against rebates
A dispute is brewing among pharmaceutical companies, after 10 local leading drug manufacturers re-pledged on January 14 to stop the practice of giving “illegal rebates'' here.
These large pharmaceutical firms said ...
